Add the diluent down the side of the vial rather than directly onto the cake. It is slower and it avoids the foaming that makes people think something has gone wrong.
A 10 mg vial reconstituted three different ways, compared — the long version
Where I part company with post #14, and it is a narrow parting.
A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently rather than shaken hard, is the injection technique clean, is the vial integrity intact. Work through that checklist before concluding the powder is insoluble.
That is one dataset and I would not build a rule on it.
Two people can reconstitute the same vial to different concentrations and both be right. The dose is the same; only the volume drawn differs. This confuses more discussions here than any other single point.
Adding the caveat now so it does not have to be extracted later.
Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile indefinitely, and no supplier claims otherwise.
Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so each unit = 0.025 mg. A 0.25 mg dose = 0.25 / 0.025 = 10 units. Different concentration: different arithmetic, same principle.
Noting that the question and the thing people usually mean by it are different.
Write the reconstitution date and the concentration on the vial. Not on a note, on the vial. Every account here of a dosing error involving the wrong concentration involves a vial with nothing written on it.
A guess, clearly labelled as one.
I would call the community position on 10 mg vial reconstituted three likely rather than established, and I would be comfortable defending that hedge.
Read the full topic (159 posts)
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Coming back to: Why I now write the concentration on the vial in marker
The question in the title: Why I now write the concentration on the vial in marker I will give what I have already checked below so nobody repeats it. Writing this out with the numbers in it, because…
|
+8 | 12 | 4.3k | 1d |
|
Reconstituting a multi-strength kit without mixing yourself up — what changed since
On the subject in the title: Reconstituting a multi-strength kit without mixing yourself up — what changed since Working notes rather than a conclusion. What changes if the standard account of Reconstituting…
|
+42 | 46 | 1k | 7h |
|
Checking someone else's arithmetic: a worked example thread
Checking someone else's arithmetic: a worked example thread Writing it up because I had to work it out twice and would rather nobody else did. Practical question with the units stated, because I have seen how…
|
+74 | 78 | 895 | 11mo |
|
Foaming during reconstitution and whether it matters
Posting this under the heading it deserves: Foaming during reconstitution and whether it matters Everything below is what sits behind that. A follow-up question about foaming during reconstitution that I did…
|
+19 | 24 | 466 | 11mo |
|
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since
Posting this under the heading it deserves: A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Everything below is what sits behind that. 5 mg vial: setting out the arithmetic in…
|
+86 | 93 | 25k | 13mo |
Related topics — sharing the tags reconstitution, syringe units, worked example
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
An ABAB design with a data table and honest limitations — a second dataset
On the subject in the title: An ABAB design with a data table and honest limitations — a second dataset Working notes rather than a conclusion. Posting a small dataset on ABAB design. It is mine, it is…
|
+106 | 118 | 25k | 4mo |
|
Follow-up: Why "dose equivalence" between different incretin analogues is a weak concept
Asking directly, because I could not find a straight answer: Why "dose equivalence" between different incretin analogues is a weak concept I have read the maintained page on this and I still have a gap, so I…
|
+7 | 11 | 26k | 9mo |
|
Follow-up: Escalating every six weeks instead of four: what I observed over eight months
Escalating every six weeks instead of four: what I observed over eight months — setting out what I have, and where I think it stops being reliable. Two things I would like separated before anyone answers on…
|
4 | 164 | 20mo | |
|
Coming back to: Washout: how long is long enough, and for what purpose
Posting this under the heading it deserves: Washout: how long is long enough, and for what purpose Everything below is what sits behind that. A narrow question about Washout, deliberately narrow, because the…
|
+128 | 139 | 3k | 3mo |
|
Pre-registering a personal experiment, seriously
Pre-registering a personal experiment, seriously — setting out what I have, and where I think it stops being reliable. A narrow question about pre-registering a personal experiment, deliberately narrow,…
|
+96 | 119 | 58k | 14mo |